Silver Spring, MD – The U.S. Food and Drug Administration (FDA) continues to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
As part of the FDA’s effort to protect consumers, the FDA and the Federal Trade Commission issued warning letters to two companies for selling fraudulent COVID-19-related products.
There are currently no FDA-approved products to prevent or treat COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
The first company, Griffo Botanicals, offers herbal tincture products for sale in the United States with misleading claims that the products can mitigate, prevent, treat, diagnose, or cure COVID-19 in people.
The second company, Prairie Dawn Herbs, offers herbal products for sale in the United States with misleading claims that the products can mitigate, prevent, treat, diagnose, or cure COVID-19 in people.
As of today, 278 tests are authorized by FDA under EUAs; these include 217 molecular tests, 55 antibody tests, and 6 antigen tests.
About the U.S. Food and Drug Administration
The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.